Mint or not? study tests Smokers' preferences for nicotine gum and inhalers
NCT ID NCT02020005
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study involved 60 African American menthol smokers who tried six different nicotine replacement products, including mint-flavored and non-flavored gum and inhalers. After two weeks of sampling, they chose one product to help them quit smoking for another two weeks. The goal was to understand which flavors and nicotine strengths they liked best, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nicotine gum and nicotine inhaler (mint-flavored and non-flavored)
What this could lead to
If successful, this could help design better smoking cessation programs tailored to menthol smokers' preferences.
What could go wrong
This is a small, completed preference study, not a treatment trial. Results may not apply to all smokers or lead directly to new therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States